EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
Alterity Therapeutics Limited - Sponsored ADR (ATHE) EBITDA Margin data is not available for the most recently reported fiscal year, ending 2024-06-30.
| Income Statement Financials | |
-- |
|
$-12.54M |
|
-- |
|
-- |
|
$15.18M |
|
$-15.18M |
|
$2.67M |
|
$-12.51M |
|
$-12.51M |
|
$-12.54M |
|
$-12.54M |
|
$-12.54M |
|
$-12.54M |
|
$-15.18M |
|
$-15.09M |
|
6.08M |
|
6.08M |
|
$-2.05 |
|
$-2.05 |
|
| Balance Sheet Financials | |
$12.48M |
|
$0.02M |
|
$0.12M |
|
$12.61M |
|
$3.52M |
|
-- |
|
$0.03M |
|
$3.56M |
|
$9.05M |
|
$9.05M |
|
$9.05M |
|
8.74M |
|
| Cash Flow Statement Financials | |
$-8.27M |
|
$-0.00M |
|
$6.04M |
|
$10.34M |
|
$8.29M |
|
$-2.06M |
|
$0.58M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.54 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
EBITDA Margin |
-- |
-- |
|
-- |
|
$-8.27M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-138.60% |
|
-138.60% |
|
-99.48% |
|
-138.60% |
|
$1.04 |
|
$-1.36 |
|
$-1.36 |
|